Gilead teams up with WHO again to eliminate parasitic tropical disease - Pharmaceutical Technology

Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis. Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis. Over 90 sandfly species are known to transmit the parasitic protozoan Leishmania. Credit: Andrzej Rostek/Shutterstock.com. Gilead has pledged over 400,000 doses of its antifungal medication to countries affected by a parasitic tropical disease as part of a renewed partnership with the World Health Organization (WHO). Since 2011, Gilead has provided more than 1.1 million vials of AmBisome (liposomal amphotericin B for injection) and over $18m to…

Source: Pharmaceutical Technology